We have shown that spontaneous isotype switch variants occur at low frequency in myeloma and hybridoma cell lines. These cells have deleted the wild-type C H gene from the active chromosome. The recombination mostly happens outside the 'switch-regions'. LPS-stimulated B cells, however, switch isotype frequently and delete C p from both chromosomes. consistent with X-ray crystallographic studies which demonstrate that contact residues within both Cy2 and Cy3 domains are necessary for SpA binding (Marquart & Deisenhofer, 1982). Histidine-435 located within the interdomain region is essential to SpA binding and IgG3 proteins having arginine at this position do not bind SPA. It is interesting to note that 'general' rheumatoid factor recognizes the Ga antigen which is also expressed in IgG 1 , 2 and 4 but not IgG3 proteins. Similarly, a number of murine McAbs were produced that had a non-IgG3 specificity. The possibility that these McAbs overlap in molecular specificity with human rheumatoid factor and the SpA binding site was investigated in parallel studies with a monoclon.tl human IgM rheumatoid factor (RF-AN) secreted by an Epstein-Barr-virus-transformed lymphocyte cell line (Jefferis et al., 1984). Neither protein TIM or SIZ expressed the epitope recognized by RF-AN and the non-IgG3 murine McAb suggesting that the quaternary structure of the intact Fc is essential for reactivity with these antibodies. Studies employing an IgG3( 15,16) protein of non-Caucasian origin allowed further structural definition of the epitope recognized. Caucasian IgG3 proteins are characterized by the presence of arginine at position 435. However, a common mongoloid allotype IgG3m( 15,16) has been shown to have histidine at residue 435. These proteins bind to SpA (Van Loghem et al., 1982). The rheumatoid factor RF-AN and the murine non-IgG3 McAb all were reactive to high titre with IgG3m(15,16) protein GOE. Thus histidine-435 is critical to the expression of a conformational epitope localized to the interdomain region of IgG molecules.
Equivocal and often contradictory results have been obtained using proteolytic fragments and sub-fragments of human IgG to localize sites controlling effector functions. In contrast hinge-deleted paraproteins have made a significant contribution to our understanding of structure-function relationships and allow the C l q binding site to be localized to the N-terminal region of the Cy2 domain (Klein et al., 1981) . Similar studies employing a series of variants resulting from genetic or biosynthetic abnormalities may allow sites controlling other effector functions to be precisely mapped.
Recently we have isolated two paraproteins, TIM and SIZ, having extensive or complete deletions of the Cy2 and Cy3 domains respectively (Nik Jaafar et al., 1983 , 1984 consistent with X-ray crystallographic studies which demonstrate that contact residues within both Cy2 and Cy3 domains are necessary for SpA binding (Marquart & Deisenhofer, 1982) . Histidine-435 located within the interdomain region is essential to SpA binding and IgG3 proteins having arginine at this position do not bind SPA. It is interesting to note that 'general' rheumatoid factor recognizes the Ga antigen which is also expressed in IgG 1 , 2 and 4 but not IgG3 proteins. Similarly, a number of murine McAbs were produced that had a non-IgG3 specificity. The possibility that these McAbs overlap in molecular specificity with human rheumatoid factor and the SpA binding site was investigated in parallel studies with a monoclon.tl human IgM rheumatoid factor (RF-AN) secreted by an Epstein-Barr-virus-transformed lymphocyte cell line (Jefferis et al., 1984) . Neither protein TIM or SIZ expressed the epitope recognized by RF-AN and the non-IgG3 murine McAb suggesting that the quaternary structure of the intact Fc is essential for reactivity with these antibodies. Studies employing an IgG3( 15,16) protein of non-Caucasian origin allowed further structural definition of the epitope recognized. Caucasian IgG3 proteins are characterized by the presence of arginine at position 435. However, a common mongoloid allotype IgG3m( 15,16) has been shown to have histidine at residue 435. These proteins bind to SpA (Van Loghem et al., 1982) . The rheumatoid factor RF-AN and the murine non-IgG3 McAb all were reactive to high titre with IgG3m(15,16) protein GOE. Thus histidine-435 is critical to the expression of a conformational epitope localized to the interdomain region of IgG molecules.
Neither protein TIM or SIZ inhibited polyclonal IgG binding to monocytes (Woof et al., 1984) , suggesting that the effector site recognized by Fc receptor is contributed to by both Cy2 and Cy3 domains either directly or through the C1, IgG and IgM molecules all co-exist within the blood plasma and yet no activation of C1 takes place. What then are the changes that take place in the IgG and IgM molecules following their combination with antigen that allows the C1 molecule to be bound and why does this binding result in activation? Although C1 can be bound and activated by surfaces without the participation of antibody, it seems probable that C1 and Ig have evolved in a co-operative manner so that the requirements for C1 activation are met by the structural organization of Ig. Thus, in order to discuss effector mechanisms of Ig molecules, it is necessary to delineate the requirements of the C1 molecule.
It is now well recognized that the binding of C1 to immune complexes and the subsequent activation of the molecule are two separate processes and activation does not inevitably follow binding. The C l molecule is a composite molecule consisting of two subcomponents: (1) a linear tetramer containing two C l r and two Cls molecules, which are serine esterases in the zymogen form, and (2) the Clq moiety, which has no enzymic activity and is essentially a mechanical tool for binding the zymogens to the immune complexes. The Clq molecule has six binding sites for complexes, one site on each of its 'heads', and the essential requirement for stable binding is that at least two of the heads must be involved. Binding by a single bond is so weak that it lasts for less than a second (approx. K = 5 x l O 4~-' ) , whereas divalent binding lasts for several minutes on average (approx. K = 5 x ~O'M-') and the dissociation rate for three-headed binding is measured in hours (approx. K = 1 x ~O'OM-I) (Hughes-Jones, 1977) . Clr and C 1 s exist as single polypeptides of about 85 000 M , and on activation are split into two unequal chains, the smaller chain acquiring the active enzyme site. The Clr molecule is split first and then acts on CIS. What is unknown at the present time is the mechanism by which C l r is split following Clq binding. Two suggestions have been made. First, that there is an allosteric change in Clq which leads to an allosteric change in a C 1 r molecule and that this results in the appearance of an active enzyme site. Secondly, it is suggested that a separate binding site on the immune complex for the ClrCls tetramer is essential and that the binding of the tetramer to both Clq and the complex allows for autoAbbreviation used: Ig, immunoglobulin. activation of the enzyme (Goers et al. , 1977; Hughes-Jones & Gorick, 1982) .
Turning now to IgM, we do know that this is a molecule that can exist in two forms. Pentameric IgM in solution has a central (Fc), disc from which F(ab)z arms extend radially, the disc and the arms being in the same plane. The (Fc), disc contains the Cp2 domain (which is the equivalent of the hinge region in IgG) together with the Cp3 and Cp4 domains (Feinstein & Beale, 1977) . When forming complexes in antigen excess, most of the IgM molecules retain this planar form, whereas complexes in antibody excess have IgM mainly in a 'staple' form with the F(ab)z domains bent at right angles to the central ( F c )~ disc. We have looked at C1 binding and activation by complexes in both antigen and antibody excess. The antigen used was dextran particles and the antibody, the mouse myeloma MOPC 104E. Clq binds well to antibody present in the staple form, almost all the IgM molecules being able to form stable binding sites with a K of about 5 x IO'M-', indicating binding by two heads. Moreover, activation of C1 is rapid, being complete in about 15 min.
On the other hand, in antigen excess, with IgM mainly in the planar form, Clq binding occurs but only about 10% of the IgM molecules have binding sites. The binding constant for Clq-IgM interaction is also of the order of 5 x lo7 M -I , indicating binding by two heads, but it is not clear whether the binding that does take place is to a few molecules which may be in the staple form or whether binding can take place with some IgM molecules when still in the planar form. Although C1 binds under these circumstances, it does not activate, showing that whatever the conditions are that lead to activation, they are not present in antigen excess. These findings indicate that sites for C 1 q binding become available when the IgM molecule acquires the staple shape and also that the correct conditions are then present for C1 activation.
The next question is, what is the mechanism for the appearance of Clq binding sites when IgM assumes the staple form? In order to answer this, we have looked at the binding of Clq to the intact IgM pentamer and to various fragments of IgM. The binding constant for the Clqpentamer IgM reaction is of the order of 5 x lo5 M -I , a relatively weak reaction indicating that only one binding site is available. A similar value is obtained for C 1 q binding to the pentameric (Fc), disc (Cp3 and Cp4 domains). The similarity between these K values indicates that no additional C 1 q binding sites become exposed by removal of the F(ab), arms. The F(ab')z fragments have no sites for Clq binding. On the other hand, 7s subunits containing all the variable and constant domains are able to bind Clq. These findings indicate (1) that the 7s IgM subunits each have a pre-existing binding site, (2) that in the assembly of the
